Torrent Pharmaceuticals
Torrent Pharmaceuticals (India) holds 41 active US FDA Type II Drug Master Files and 5 inactive, has DMF or CEP filings on record for 40 active ingredients and is linked to 5 FDA-registered manufacturing sites. 17 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Torrent Pharmaceuticals: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/torrent-pharmaceuticals
Overview
Torrent Pharmaceuticals is a leading pharmaceutical company based in India, known for its wide-ranging portfolio of generic and branded drugs. The company is committed to producing high-quality healthcare solutions in various therapeutic areas to meet global healthcare needs.
Core services & business areas
Active ingredients with DMF or CEP filings
Substances for which Torrent Pharmaceuticals holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
Torrent Pharmaceuticals holds 41 active (46 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- AVATROMBOPAG MALEATEActive2026-06-06
- LEVOKETOCONAZOLEActive2025-08-30
- VERICIGUATActive2024-11-22
- STIRIPENTOLActive2023-12-29
- PRUCALOPRIDE SUCCINATEActive2023-06-04
- ZOLPIDEM TARTRATE USPActive2023-02-23
- PENCICLOVIRActive2021-10-29
- ROFLUMILAST USPActive2021-03-11
- ALOGLIPTIN BENZOATEActive2020-12-11
- FEBUXOSTATActive2020-11-02
- SITAGLIPTIN PHOSPHATE MONOHYDRATE USPActive2018-01-19
- SILODOSINActive2016-11-15
- DIMETHYL FUMARATE USPActive2016-09-26
- RASAGILINE MESYLATEActive2016-06-21
- ANAGRELIDE HYDROCHLORIDE USPActive2015-07-13
- GUANFACINE HYDROCHLORIDE USPActive2014-08-04
- LURASIDONE HYDROCHLORIDEActive2014-04-22
- ESOMEPRAZOLE MAGNESIUM TRIHYDRATE USPActive2013-10-31
- REPAGLINIDEActive2012-01-03
- DARIFENACIN HYDROBROMIDEActive2011-12-08
- MONTELUKAST SODIUMActive2011-04-01
- TELMISARTAN USPActive2011-03-25
- OLMESARTAN MEDOXOMIL USPActive2010-09-29
- ALFUZOSIN HYDROCHLORIDE USPActive2010-03-22
- ESOMEPRAZOLE MAGNESIUM USPActive2009-09-14
- NEBIVOLOL HYDROCHLORIDEActive2009-06-29
- QUETIAPINE FUMARATEActive2009-03-30
- CANDESARTAN CILEXETILActive2009-03-30
- ATORVASTATIN CALCIUMActive2009-02-26
- OLANZAPINEActive2009-02-18
- SILDENAFIL CITRATEActive2008-10-31
- RABEPRAZOLE SODIUM USPActive2008-06-26
- RISPERIDONEActive2008-05-19
- PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATEActive2008-05-19
- DULOXETINE HYDROCHLORIDE USPActive2008-03-31
- DONEPEZIL HYDROCHLORIDE USPActive2007-11-01
- TOPIRAMATEActive2007-03-28
- LAMOTRIGINE USPActive2007-02-22
- ROPINIROLE HYDROCHLORIDE DRUG SUBSTANCEActive2005-09-14
- VENLAFAXINE HYDROCHLORIDE USPActive2005-08-30
- SERTRALINE HYDROCHLORIDE DRUG SUBSTANCEActive2005-04-29
- LEVODOPAInactive2011-11-11
- TELMISARTANInactive2010-11-11
- PALIPERIDONEInactive2010-06-29
- CLOPIDOGREL BISULPHATE FORM-IInactive2010-01-21
- CLOPIDOGREL BISULPHATE FORM IIInactive2008-01-16
Registered manufacturing sites (5)
Physical sites registered with the US FDA and resolved to Torrent Pharmaceuticals, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
- Torrent Pharmaceuticals LimitedVisakhapatnam, India · API manufacture
- Torrent Pharmaceuticals LimitedBharuch, India · API manufactureSite GMP match
- Torrent Pharmaceuticals LimitedIndrad, India · API manufactureSite GMP match
- Torrent Pharmaceuticals LimitedPithampur, India · Analytical testing · Drug manufactureSite GMP match
- Torrent Pharmaceuticals LimitedGandhinagar, India · Analytical testing · Drug manufactureSite GMP match
FDA compliance signals
17 FDA enforcement records linked to this company.
- 4832023-05-25
Computer control of master formula records
- 4832023-05-25
Investigations of discrepancies, failures
- 4832022-09-28
Cleaning / Sanitizing / Maintenance
- 4832022-09-28
Written record of complaint to include findings, follow-up
- 4832022-09-28
Investigations of discrepancies, failures
- warning_letter2019-10-08
FDA Warning Letter (drug product)
- 4832018-06-15
Failure to develop written procedures
- 4832018-06-15
Periodic safety report missing ICSR
- 4832018-06-15
Late submission of an ICSR
- recall — Class III2016-04-27
Presence of Foreign Substance: Product complaint for the presence of foreign matter identified as silicone within the tablet.
- 4832013-07-26
Test methods
- 4832009-04-16
Prepared for each batch, include complete information
- 4832009-04-16
Scientifically sound laboratory controls
- 4832009-04-16
Investigations of discrepancies, failures
- 4832009-04-16
Written procedures not established/followed
- 4832009-04-16
Cleaning / Sanitizing / Maintenance
- 4832009-04-16
Control procedures to monitor and validate performance
Is this Torrent Pharmaceuticals?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.